In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against Gram-positive and Gram-negative pathogens from respiratory tract infections

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 3, 1997, Pages 427-431

  Hoogkamp Korstanje, J A A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; OFLOXACIN; PEFLOXACIN; SPARFLOXACIN; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; KLEBSIELLA PNEUMONIAE; LEGIONELLA PNEUMOPHILA; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; OFLOXACIN; PEFLOXACIN; QUINOLONES; RESPIRATORY TRACT INFECTIONS;

EID: 1842414243     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.3.427     Document Type: Article

References (10)

1. Hoogkamp-Korstanje, J. A. A. (1989). In vitro and in vivo activity of five fluoroquinolones against common pathogens. Journal of Drug Development 2, 93-101.
2. Neu, H. C. (1992). An update of fluoroquinolones. Current Opinion in Infectious Diseases 5, 755-63.
3. Piddock, L. J. (1994). New quinolones and Gram-positive bacteria. Antimicrobial Agents and Chemotherapy 38, 163-9.
4. Bongaerts, G. P. & Hoogkamp-Korstanje, J. A. A. (1993). In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against Gram-positive and Gram-negative pathogens from respiratory tract and soft tissue infections. Antimicrobial Agents and Chemotherapy 37, 2017-9.
5. Pankuch, G. A., Jacobs, M. R. & Appelbaum, P. C. (1995). Activity of CP,99219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci. Journal of Antimicrobial Chemotherapy 35, 230-2.
6. Visalli, M. A., Jacobs, M. R. & Appelbaum, P. C. (1996). Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology. Journal of Antimicrobial Chemotherapy 37, 77-84.
7. Spangler, S. K., Jacobs, M. R. & Appelbaum, P. C. (1992). Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, Win 57273, ofloxacin and ciprofloxacin. Antimicrobial Agents and Chemotherapy 36, 856-9.
8. Blumberg, H. M., Rimland, D., Carroll, D. J., Terry, P. & Wachsmuth, I. K. (1991). Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. Journal of Infectious Diseases 163, 1279-85.
9. Schaberg, D. R., Dillon, W. I., Terpenning, M. S., Robinson, K. A., Bradley, S. F. & Kauffman, C. A. (1992). Increasing resistance of enterococci to ciprofloxacin. Antimicrobial Agents and Chemotherapy 36, 2533-5.
10. Tabuko, T. (1992). Annual changes of the susceptibility of clinical isolates to ofloxacin. In Abstracts of the Fourth International Symposium on New Quinolones, Abstract 12.